праздник ко дню воспитателя в детском саду в газету
Главное меню:
Интересное
праздник ко дню воспитателя в детском саду в газету, label - Food and Drug Administration, Dapagliflozin: Package Insert / Prescribing Information - Drugs.com, CKD | Type 2 Diabetes | Heart Failure | FARXIGA | For HCPs, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, AstraZeneca Pharmaceuticals LP FARXIGA- dapagliflozin tablet, film coated, DailyMed - FARXIGA- dapagliflozin tablet, film coated, Farxiga Prescribing Information - Mayo.
ffЈ=W} w5?zn7O[-{1F-(^5W?JB5F som#+DLewJ($+dbJdW"/ZS[γ4T Y 侻 =|$}wo/ \M"3747bHC1e9xXmmhNӏ4Pjy֜&_g{ӄsz{4X-r ':hTvA0)&3 G$i0wqAc/ڹ4l* Y\6^y^:L:VRAC9BCL8ҥ+RUEXPMOk nIf;([6l*b{ow wG$Z&'c_skVe3gK%@-~rRlߪo `^}moWHñgnZw]9GbWGF!%IñnJؑg\}Wbﮜoli>aE?~4; ~ q O&_yp 9cwnrtNrA>;dZ I `|>qط(wI;䴒v8ÞtruLƴ\ј$ڪ]㥐b RoR, HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA® (dapagliflozin) tablets, for oral use Initial U.S. Approval: 2014 ---------------------------RECENT MAJOR CHANGES--------------------------, Dapagliflozin package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology..
You may report side effects related to AstraZeneca products . FARXIGA ® (dapagliflozin) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2024. Virani SS, Alonso A, Benjamin EJ, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee., FORXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg or 10 mg dapagliflozin as dapagliflozin propanediol monohydrate. FORXIGA 5 mg tablets are yellow, biconvex, round, film coated tablets with “5” engraved on one side and “1427” engraved on the other side., The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone , These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA® (dapagliflozin) tablets, for oral , Dapagliflozin is extensively metabolized, primarily to yield dapagliflozin 3-O-glucuronide, which is an inactive metabolite. Dapagliflozin 3-O-glucuronide accounted for 61% of a 50 mg [14C]-dapagliflozin dose and is the predominant drug-related component in human plasma., FARXIGA® (dapagliflozin) tablets are used to improve glycemic control in adults with type 2 diabetes..